SCHOTT Pharma AG & Co. KGaA Operating Cash Flow for the year ending September 30, 2024:
USD 250.89 M
SCHOTT Pharma AG & Co. KGaA Operating Cash Flow is USD 250.89 M for the year ending September 30, 2024, a 30.62% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
SCHOTT Pharma AG & Co. KGaA Operating Cash Flow for the year ending September 30, 2023 was USD 192.08 M, a 7.61% change year over year.
-
SCHOTT Pharma AG & Co. KGaA Operating Cash Flow for the year ending September 30, 2022 was USD 178.49 M, a 16.63% change year over year.
-
SCHOTT Pharma AG & Co. KGaA Operating Cash Flow for the year ending September 30, 2021 was USD 153.04 M, a 25.09% change year over year.
-
SCHOTT Pharma AG & Co. KGaA Operating Cash Flow for the year ending September 30, 2020 was USD 122.34 M.